Morningstar Inc. points out that many firms use artificial intelligence as a reason to reduce staff and cut costs instead of using the technology to increase efficiency. The focus in the market is often on what AI could eliminate, not on how it can create value. Analyst Lochlan Halloway noted
Incarceration can turn minor health issues into life-threatening situations. Across the U. S. , people in prisons, jails, and detention centers often face severe consequences due to delayed or ignored medical care. For instance, a broken arm in a Mississippi prison led to amputation, and a man in a
Income investing isn't just about chasing the highest yields. In today's world, where interest rates are high and economic conditions are tougher, investors need to think more carefully. It's not enough to just look at the yield. You need to consider if the investment can survive when things get rou
Incels, or involuntary celibates, are a group of mostly young men who struggle with forming romantic relationships. They often blame women for their lack of a sex life and express their frustrations online. The incel community has gained attention recently, partly due to a popular Netflix show that
Inclusion and recognition are big deals for people with spinal cord injuries. How do they feel about it in Norway, The Netherlands, and Australia? That's what this piece looks into. It's all about how mobility issues and social attitudes play out in these different places. First off, let's talk
Incredibly, a small twist in super-thin materials can make a big difference in how heat moves through them. Scientists found that rotating layers of materials like molybdenum disulfide, carbon, and boron nitride by just 1 to 4 degrees creates a barrier that hinders heat flow. It's like having a spec
Incoming Senate Majority Leader John Thune (R-SD) is planning some big changes. One of the first things he wants to do is make the Senate work more days. Instead of the usual four days a week, Thune is thinking about five-day workweeks. This is to help get more done, especially in the first 100 days
Inclisiran, a drug designed to reduce lipoprotein cholesterol levels and minimize cardiovascular disease risk, is currently under scrutiny for its adverse effects. Researchers have dived into the FDA's Adverse Event Reporting System to examine real-world data on inclisiran's potential dangers. This
